MOGA Young Oncologists to attend ESMO Targeted Anticancer Therapies (TAT) Asia Congress 2025

MOGA congratulates Dr Jun Beng Kong of Townsville University Hospital and Dr Wei Yen Chan of Macquarie University Hospital as our Young Oncologist members to receive non-abstract-related travel grants to attend the inaugural ESMO TAT Asia Congress. Their attendance will be supported by ESMO as part of MOGA’s endorsement of the meeting.

To be held on 18-20 July 2025 in Hong Kong SAR, China the inaugural ESMO TAT Asia 2025 is a pioneering platform designed to bring together key stakeholders in early drug development in the Asia-Pacific region. The meeting will focus on building capacity and accelerating the development of early phase clinical trials, creating strong foundations for oncology drug development. More information about the Congress can be found on their website: ESMO Targeted Anticancer Therapies Asia Congress 2025.